|
Real-time Estimate
Tradegate
12:09:04 21/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 122.22 EUR | +0.25% |
|
-8.72% | -26.04% |
| 19/08 | Oracle Health Expands Clinical AI Agent With New AI Documentation Capabilities | MT |
| 19/08 | Oracle Health Announces New Capabilities For Oracle Health Clinical AI Agent In The U.S | CI |
Company Valuation: Oracle Corporation
Data adjusted to current consolidation scope
| Fiscal Period: May | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 191,894 | 286,017 | 322,098 | 464,185 | 649,354 | 414,241 | - | - |
| Change | - | 49.05% | 12.62% | 44.11% | 39.89% | -36.21% | - | - |
| Enterprise Value (EV) 1 | 245,851 | 366,311 | 398,306 | 545,550 | 747,001 | 546,351 | 579,899 | 592,081 |
| Change | - | 49% | 8.73% | 36.97% | 36.93% | -26.86% | 6.14% | 2.1% |
| P/E | 29.8x | 34.5x | 31.6x | 38.1x | 38.7x | 22.5x | 16.1x | 11x |
| PBR | -34.7x | 268x | 34.9x | 22x | 15.3x | 4.95x | 3.53x | 2.93x |
| PEG | - | 1.3x | 1.5x | 2.2x | 1.1x | 2.32x | 0.4x | 0.2x |
| Capitalization / Revenue | 4.52x | 5.73x | 6.08x | 8.09x | 9.64x | 4.64x | 3.17x | 2.28x |
| EV / Revenue | 5.79x | 7.33x | 7.52x | 9.5x | 11.1x | 6.12x | 4.44x | 3.25x |
| EV / EBITDA | 11.4x | 15.6x | 15.2x | 18.9x | 20.4x | 10.9x | 8.06x | 5.58x |
| EV / EBIT | 12.5x | 17.5x | 17.3x | 21.8x | 25.8x | 15.2x | 11.9x | 8.85x |
| EV / FCF | 48.9x | 43.2x | 33.7x | -1,385x | -31.5x | -11.4x | -13.7x | 43x |
| FCF Yield | 2.05% | 2.31% | 2.96% | -0.07% | -3.17% | -8.74% | -7.31% | 2.33% |
| Dividend per Share 2 | 1.28 | 1.36 | 1.6 | 2 | 2 | 2.04 | 2.153 | 2.388 |
| Rate of return | 1.78% | 1.28% | 1.37% | 1.21% | 0.89% | 1.42% | 1.5% | 1.66% |
| EPS 2 | 2.41 | 3.07 | 3.71 | 4.34 | 5.83 | 6.396 | 8.93 | 13.13 |
| Distribution rate | 53.1% | 44.3% | 43.1% | 46.1% | 34.3% | 31.9% | 24.1% | 18.2% |
| Net sales 1 | 42,440 | 49,954 | 52,961 | 57,399 | 67,357 | 89,337 | 130,637 | 182,039 |
| EBITDA 1 | 21,565 | 23,428 | 26,184 | 28,900 | 36,549 | 49,996 | 71,963 | 106,132 |
| EBIT 1 | 19,593 | 20,902 | 23,055 | 25,033 | 28,926 | 35,897 | 48,589 | 66,900 |
| Net income 1 | 6,717 | 8,503 | 10,467 | 12,443 | 16,984 | 19,063 | 27,626 | 42,316 |
| Net Debt 1 | 53,957 | 80,294 | 76,208 | 81,365 | 97,647 | 132,110 | 165,658 | 177,841 |
| Reference price 2 | 71.92 | 105.94 | 117.19 | 165.53 | 225.78 | 143.81 | 143.81 | 143.81 |
| Nbr of stocks (in thousands) | 2,668,157 | 2,699,802 | 2,748,514 | 2,804,234 | 2,876,046 | 2,880,471 | - | - |
| Announcement Date | 13/6/22 | 12/6/23 | 11/6/24 | 11/6/25 | 10/6/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 22.48x | 6.12x | 10.93x | 1.42% | 414B | ||
| 26.39x | 5.28x | 16.59x | 1.44% | 250B | ||
| 82.34x | 8.01x | 21.43x | -.--% | 132B | ||
| 38.48x | 3.6x | 13.24x | 0.18% | 47.58B | ||
| -52.69x | 86.35x | 744.21x | -.--% | 40.06B | ||
| 30.77x | 11.94x | 19.5x | -.--% | 25.09B | ||
| 37.11x | 2.45x | 22.28x | -.--% | 20.32B | ||
| 104x | 9.97x | 42.48x | -.--% | 15.08B | ||
| -637.65x | 3.78x | 12.65x | - | 13.82B | ||
| Average | -38.75x | 15.28x | 100.37x | 0.38% | 106.43B | |
| Weighted average by Cap. | 21.66x | 9.49x | 45.62x | 1.01% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ORCL Stock
- ORC Stock
- Valuation Oracle Corporation
Select your edition
All financial news and data tailored to specific country editions
















